Published in
American Society for Microbiology, Journal of Clinical Microbiology, 1(50), p. 134-137, 2012
DOI: 10.1128/jcm.05446-11
Links
- American Society for Microbiology | PDF
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Israel: Dissemination of Global Clones and Unique Features
,
A. Embon,
E. Khabra,
Y. Paitan,
L. Keren,
E. Halperin,
Y. Carmeli,
M. J. Schwaber
Full text: Download
Abstract
ABSTRACT From 2006 to 2009, 315 clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates were collected from 5 hospitals across Israel. Most isolates (64%) were related to the global clones spa types t001-SCC mec -I (SCC mec -I stands for staphylococcal cassette chromosome mec type I) ( n = 99; 31%), t002-SCC mec -II ( n = 82; 26%), and t008-SCC mec -IV ( n = 21; 7%), five of which were identified as MRSA strain USA-300. Seventeen strains unique to Israel were identified. SCC mec types IV and V were common among hospital-acquired isolates.